Usa state Florida state Washington state Rhode Island treating adults treating kids Manufacturing Usa state Florida state Washington state Rhode Island

Survey: Persistent Adderall Shortage Disrupts ADHD Treatment Nationwide

Reading now: 219
www.additudemag.com

September 16, 2022The Adderall shortage reported earlier this summer spurred by labor constraints at a plant run by drug manufacturer Teva Pharmaceuticals is creating a trickle-down effect that is making generic forms of the ADHD medication difficult to find and fill across the United States.

According to the American Society of Health-System Pharmacists (ASHP), three additional drug manufacturers — who together with Teva provide one-half of the U.S.

supply of generic Adderall — are now reporting supply shortfalls. Because Adderall (dextroamphetamine-amphetamine, or amphetamine salts) is a Schedule 2 controlled substance, the federal government limits the amount that any one company is allowed to manufacture.

Read more on additudemag.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

DMCA